Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.eururo.2020.03.030 http://scihub22266oqcxt.onion/10.1016/j.eururo.2020.03.030 32249089!7270372!32249089     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+Urol 2020 ; 77 (6): 742-747 Nephropedia Template TP {{tp|p=32249089|t=2020. Identification of Kidney Transplant Recipients with Coronavirus Disease 2019 |pdf=|usr=}}{{32249089}} gab.com Text Identification of Kidney Transplant Recipients with Coronavirus Disease 2019 JO: Eur Urol http://www.kidney.de/pget.php?&tw=1&pmid=32249089 #FOAvip Coronavirus disease 2019 (COVID-19) is a novel and lethal infectious disease, posing a threat to global health security. The number of cases has increased rapidly, but no data concerning kidney transplant (KTx) recipients infected with COVID-19 are available. To present the epidemiological, clinical, and therapeutic characteristics of KTx recipients infected with COVID-19, we report on a case series of five patients who were confirmed as having COVID-19 through nucleic acid testing (NAT) from January 1, 2020 to February 28, 2020. The most common symptoms on admission to hospital were fever (five patients, 100%), cough (five patients, 100%), myalgia or fatigue (three patients, 60%), and sputum production (three patients, 60%); serum creatinine or urea nitrogen levels were slightly higher than those before symptom onset. Four patients received a reduced dose of maintenance immunosuppressive therapy during hospitalization. As of March 4, 2020 NAT was negative for COVID-19 in three patients twice in succession, and their computed tomography scans showed improved images. Although greater patient numbers and long-term follow-up data are needed, our series demonstrates that mild COVID-19 infection in KTx recipients can be managed using symptomatic support therapy combined with adjusted maintenance immunosuppressive therapy. Twit Text FOAVip Identification of Kidney Transplant Recipients with Coronavirus Disease 2019 ????Eur Urol http://www.kidney.de/pget.php?&tw=1&pmid=32249089 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32249089 #FOAvip English Wikipedia <ref>{{Cite pmid|32249089}}</ref> Identification of Kidney Transplant Recipients with Coronavirus Disease 2019 #MMPMID32249089 Zhang H; Chen Y; Yuan Q; Xia QX; Zeng XP; Peng JT; Liu J; Xiao XY; Jiang GS; Xiao HY; Xie LB; Chen J; Liu JL; Xiao X; Su H; Zhang C; Zhang XP; Yang H; Li H; Wang ZD Eur Urol 2020[Jun]; 77 (6): 742-747 PMID32249089show ga Coronavirus disease 2019 (COVID-19) is a novel and lethal infectious disease, posing a threat to global health security. The number of cases has increased rapidly, but no data concerning kidney transplant (KTx) recipients infected with COVID-19 are available. To present the epidemiological, clinical, and therapeutic characteristics of KTx recipients infected with COVID-19, we report on a case series of five patients who were confirmed as having COVID-19 through nucleic acid testing (NAT) from January 1, 2020 to February 28, 2020. The most common symptoms on admission to hospital were fever (five patients, 100%), cough (five patients, 100%), myalgia or fatigue (three patients, 60%), and sputum production (three patients, 60%); serum creatinine or urea nitrogen levels were slightly higher than those before symptom onset. Four patients received a reduced dose of maintenance immunosuppressive therapy during hospitalization. As of March 4, 2020 NAT was negative for COVID-19 in three patients twice in succession, and their computed tomography scans showed improved images. Although greater patient numbers and long-term follow-up data are needed, our series demonstrates that mild COVID-19 infection in KTx recipients can be managed using symptomatic support therapy combined with adjusted maintenance immunosuppressive therapy. |*Clinical Laboratory Techniques[MESH] |*Transplant Recipients[MESH] |Adult[MESH] |Betacoronavirus/genetics/immunology/*isolation & purification[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |China[MESH] |Coronavirus Infections/*diagnosis/therapy/virology[MESH] |Female[MESH] |Humans[MESH] |Immunocompromised Host[MESH] |Immunosuppressive Agents/administration & dosage/*adverse effects[MESH] |Kidney Transplantation/*adverse effects[MESH] |Male[MESH] |Middle Aged[MESH] |Opportunistic Infections/*diagnosis/therapy/virology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*diagnosis/therapy/virology[MESH] |Predictive Value of Tests[MESH] |SARS-CoV-2[MESH] |Severity of Illness Index[MESH] |Time Factors[MESH]Identification of Kidney Transplant Recipients with Coronavirus Diseas(epmc).pdf DeepDyve Pubget Overpricing